Prikaz rezultata 1 – 10 od 10 za pretragu '"BRCA family"', vrijeme upita: 0,01s Detaljiziraj rezultate
  1. 1
    Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

    Izdano 2025
    Teme:
    Spremi u popis
    Spremljeno u:
  2. 2
    Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

    Izdano 2025
    Teme:
    Spremi u popis
    Spremljeno u:
  3. 3
    Figure 3 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors

    Figure 3 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors od Katrina M. Lappin (9340394)

    Izdano 2025
    Teme:
    Spremi u popis
    Spremljeno u:
  4. 4
    Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

    Izdano 2025
    Teme:
    Spremi u popis
    Spremljeno u:
  5. 5
    Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

    Izdano 2025
    Teme:
    Spremi u popis
    Spremljeno u:
  6. 6
    Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

    Izdano 2025
    Teme:
    Spremi u popis
    Spremljeno u:
  7. 7
    Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification od Robert L. Hollis (15034814)

    Izdano 2025
    Teme:
    Spremi u popis
    Spremljeno u:
  8. 8
    Figure 4 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors

    Figure 4 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors od Katrina M. Lappin (9340394)

    Izdano 2025
    Teme:
    Spremi u popis
    Spremljeno u:
  9. 9
    Figure 2 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors

    Figure 2 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors od Katrina M. Lappin (9340394)

    Izdano 2025
    Teme:
    Spremi u popis
    Spremljeno u:
  10. 10
    Figure 1 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors

    Figure 1 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors od Katrina M. Lappin (9340394)

    Izdano 2025
    Teme:
    Spremi u popis
    Spremljeno u:

Alati za pretragu: